Laboratory diagnosis of hepatitis A

Future Virology

Volumn 7, Issue 5, 2012, Pages 461-472

  De Paula, Vanessa Salete ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

hepatitis A diagnosis; IgG anti HAV; IgM anti HAV; real time PCR; RT PCR

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIGEN; VIRUS RNA;

ANOREXIA; ANTIBODY DETECTION; ANTIBODY TITER; BIOCHEMISTRY; BLOOD CELL COUNT; BLOOD SAMPLING; BLOOD TRANSFUSION; BRAIN DISEASE; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); DARK URINE; DISEASE COURSE; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DRIED BLOOD SPOT TESTING; ENZYME IMMUNOASSAY; FATIGUE; FECES CULTURE; FEVER; FLU LIKE SYNDROME; FOOD CONTAMINATION; FULMINANT HEPATIC FAILURE; GENETIC VARIABILITY; GOLD STANDARD; HEPATITIS A; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; JAUNDICE; LABORATORY DIAGNOSIS; LIQUID; LIVER FAILURE; LIVER FUNCTION TEST; LIVER NECROSIS; MALAISE; MOLECULAR DIAGNOSIS; MYALGIA; NAUSEA AND VOMITING; ORAL FLUID; PRIORITY JOURNAL; PROTHROMBIN TIME; REAL TIME POLYMERASE CHAIN REACTION; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SALIVA ANALYSIS; SEROLOGY; URINALYSIS; URINE COLOR; VACCINATION; VIREMIA; VIRUS DETECTION; VIRUS LOAD; VIRUS PARTICLE; VIRUS REPLICATION; WATER CONTAMINATION;

HEPATITIS A VIRUS;

EID: 84861323921     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.12.35     Document Type: Review

References (103)

1. Provost PJ, Wolanski BS, Miller WJ, Ittensohn OL, McAleer WJ, Hilleman MR. Physical, chemical and morphologic dimensions of human hepatitis A virus strain CR326 (38578). Proc. Soc. Exp. Biol. Med. 148(2), 532-539 (1975).
2. Kiyohara T, Ouchi Y, Hasegawa Y et al. An in-house-anti-hepatitis A virus (HAV)- specific immunoglobulin M capture enzyme-linked immunosorbent assay: evaluation and application to an HAV outbreak. J. Med. Virol. 81(9), 1513-1516 (2009).
3. Gowland P, Fontana S, Niederhauser C, Taleghani BM. Molecular and serologic tracing of a transfusion-transmitted hepatitis A virus. Transfusion 44(11), 1555-1561 (2004).
4. Koff RS. Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine 10(Suppl. 1), S15-S17 (1992).
5. Hadler SC, Webster HM, Erben JJ, Swanson JE, Maynard JE. Hepatitis A in day-care centers. A community-wide assessment. N. Engl. J. Med. 302(22), 1222-1227 (1980).
6. Tong MJ, el-Farra NS, Grew MI. Clinical manifestations of hepatitis A: recent experience in a community teaching hospital. J. Infect. Dis. 171(Suppl. 1), S15-S18 (1995).
7. Müller C. The hepatitis alphabet - hepatitis A-G and TTV. Wien. Klin. Wochenschr. 111(12), 461-468 (1999).
8. Fujiwara K, Yokosuka O, Ehata T et al. Frequent detection of hepatitis A viral RNA in serum during the early convalescent phase of acute hepatitis A. Hepatology 26(6), 1634-1639 (1997).
9. Balistreri WF. Nontransplant options for the treatment of metabolic liver disease: saving livers while saving lives. Hepatology 19(3), 782-787 (1994).
10. Balayan MS. Natural hosts of hepatitis A virus. Vaccine 10(Suppl. 1), S27-S31 (1992).
11. Koff RS. Hepatitis A. Lancet 351(9116), 1643-1649 (1998).
12. Glikson M, Galun E, Oren R, Tur-Kaspa R, Shouval D. Relapsing hepatitis A. Review of 14 cases and literature survey. Medicine (Baltimore) 71(1), 14-23 (1992).
13. Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Gastroenterol. Clin. North Am. 23(3), 437-455 (1994).
14. Melnick JL. History and epidemiology of hepatitis A virus. J. Infect. Dis. 171(Suppl. 1), S2-S8 (1995
15. Akriviadis EA, Redeker AG. Fulminant hepatitis A in intravenous drug users with chronic liver disease. Ann. Intern. Med. 110(10), 838.839 (1989
16. Cuthbert JA. Hepatitis A: old and new. Clin. Microbiol. Rev. 14(1), 38.58 (2001
17. Durand F. [Clinical forms of hepatitis A]. Rev. Med. Interne. 21(1), 50.57 (2000
18. Sjogren MH, Tanno H, Fay O et al. Hepatitis A virus in stool during clinical relapse. Ann. Intern. Med. 106(2), 221.226 (1987
19. Jeli. O, Fornet-Sapcevski J, Kovacevic L, Pandak N, Jeli. D. [Recurrences of viral hepatitis A]. Acta Med. Iugosl. 44(5), 565.576 (1990
20. Bornstein JD, Byrd DE, Trotter JF. Relapsing hepatitis A: a case report and review of the literature. J. Clin. Gastroenterol. 28(4), 355.356 (1999
21. Amado LA, Marchevsky RS, de Paula VS et al. Experimental hepatitis A virus (HAV) infection in cynomolgus monkeys (Macaca fascicularis): evidence of active extrahepatic site of HAV replication. Int. J. Exp. Pathol. 91(1), 87.97 (2010
22. Costa-Mattioli M, Monpoeho S, Nicand E, Aleman MH, Billaudel S, Ferre V. Quantification and duration of viraemia during hepatitis A infection as determined by real-time RT-PCR. J. Viral Hepat. 9(2), 101.106 (2002
23. Normann A, Jung C, Vallbracht A, Flehmig B. Time course of hepatitis A viremia and viral load in the blood of human hepatitis A patients. J. Med. Virol. 72(1), 10.16 (2004
24. Cohen JI, Feinstone S, Purcell RH. Hepatitis A virus infection in a chimpanzee: duration of viremia and detection of virus in saliva and throat swabs. J. Infect. Dis. 160(5), 887.890 (1989
25. Asher LV, Binn LN, Mensing TL, Marchwicki RH, Vassell RA, Young GD. Pathogenesis of hepatitis A in orally inoculated owl monkeys (Aotus trivirgatus). J. Med. Virol. 47(3), 260.268 (1995
26. Pinto MA, Marchevsky RS, Baptista ML et al. Experimental hepatitis A virus (HAV) infection in Callithrix jacchus: early detection of HAV antigen and viral fate. Exp. Toxicol. Pathol. 53(6), 413.420 (2002
27. OffGrady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97(2), 439.445 (1989
28. Radha Krishna Y, Saraswat VA, Das K et al. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis. Liver Int. 29(3), 392.398 (2009
29. Poddar U, Thapa BR, Prasad A, Singh K. Changing spectrum of sporadic acute viral hepatitis in Indian children. J. Trop. Pediatr. 48(4), 210.213 (2002
30. Wiedmann M, Boehm S, Schumacher W, Swysen C, Zauke M. Evaluation of three commercial assays for the detection of hepatitis a virus. Eur. J. Clin. Microbiol. Infect. Dis. 22(2), 129.130 (2003
31. Stapleton JT, Lange DK, LeDuc JW, Binn LN, Jansen RW, Lemon SM. The role of secretory immunity in hepatitis A virus infection. J. Infect. Dis. 163(1), 7.11 (1991
32. Arcangeletti MC, Dussaix E, Ferraglia F, Roque-Afonso AM, Graube A, Chezzi C. Multicentric evaluation of new commercial enzyme immunoassays for the detection of immunoglobulin M and total antibodies against hepatitis A virus. Clin. Vaccine Immunol. 18(8), 1391.1394 (2011
33. Locarnini SA, Coulepis AG, Kaldor J, Gust ID. Coproantibodies in hepatitis A: detection by enzyme-linked immunosorbent assay and immune electron microscopy. J. Clin. Microbiol. 11(6), 710.716 (1980
34. Yoshizawa H, Itoh Y, Iwakiri S et al. Diagnosis of type A hepatitis by fecal IgA antibody against hepatitis A antigen. Gastroenterology 78(1), 114.118 (1980
35. Stapleton JT, Lemon SM. Neutralization escape mutants define a dominant immunogenic neutralization site on hepatitis A virus. J. Virol. 61(2), 491.498 (1987
36. Park GC, Hwang S, Yu YD et al. Intractable recurrent hepatitis A virus infection requiring repeated liver transplantation: a case report. Transplant. Proc. 42(10), 4658.4660 (2010
37. Lee HJ, Jeong HS, Cho BK et al. Evaluation of an immunochromatographic assay for the detection of anti-hepatitis A virus IgM. Virol. J. 7, 164 (2010
38. Amado LA, Villar LM, de Paula VS, Pinto MA, Gaspar AM. Exposure to multiple subgenotypes of hepatitis A virus during an outbreak using matched serum and saliva specimens. J. Med. Virol. 83(5), 768.775 (2011
39. De Paula VS, Villar LM, Coimbra Gaspar AM. Comparison of four extraction methods to detect hepatitis A virus RNA in serum and stool samples. Braz. J. Infect. Dis. 7(2), 135.141 (2003
40. Arnal C, Ferre-Aubineau V, Besse B, Billaudel S. Simplified reverse transcription polymerase chain reaction procedure with detection by microplate hybridization for routine screening of hepatitis A virus. Can. J. Microbiol. 44(3), 298.302 (1998
41. De Paula VS, Villar LM, Morais LM, Lewis-Ximenez LL, Niel C, Gaspar AM. Detection of hepatitis A virus RNA in serum during the window period of infection. J. Clin. Virol. 29(4), 254.259 (2004
42. Monteiro L, Bonnemaison D, Vekris A et al. Complex polysaccharides as PCR inhibitors in feces: Helicobacter pylori model. J. Clin. Microbiol. 35(4), 995.998 (1997
43. Fujiwara K, Yokosuka O, Ehata T et al. Association between severity of type A hepatitis and nucleotide variations in the 5L non-translated region of hepatitis A virus RNA: strains from fulminant hepatitis have fewer nucleotide substitutions. Gut 51(1), 82.88 (2002
44. Pina S, Buti M, Jardi R, Clemente-Casares P, Jofre J, Girones R. Genetic analysis of hepatitis A virus strains recovered from the environment and from patients with acute hepatitis. J. Gen. Virol. 82(Pt 12), 2955.2963 (2001
45. Costa-Mattioli M, Cristina J, Romero H et al. Molecular evolution of hepatitis A virus: a new classification based on the complete VP1 protein. J. Virol. 76(18), 9516.9525 (2002
46. Munne MS, Canero Velasco MC, Moreiro R et al. [Duration of viremia and fecal shedding of the virus in hepatitis A infected children]. Acta Gastroenterol. Latinoam. 36(4), 182.189 (2006
47. Mbayed VA, Sookoian S, Alfonso V, Campos RH. Genetic characterization of hepatitis A virus isolates from Buenos Aires, Argentina. J. Med. Virol. 68(2), 168.174 (2002
48. Bruisten SM, van Steenbergen JE, Pijl AS, Niesters HG, van Doornum GJ, Coutinho RA. Molecular epidemiology of hepatitis A virus in Amsterdam, The Netherlands. J. Med. Virol. 63(2), 88.95 (2001
49. Robertson BH, Jansen RW, Khanna B et al. Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J. Gen. Virol. 73 (Pt 6), 1365.1377 (1992
50. De Paula VS, Baptista ML, Lampe E, Niel C, Gaspar AM. Characterization of hepatitis A virus isolates from subgenotypes IA and IB in Rio de Janeiro, Brazil. J. Med. Virol. 66(1), 22.27 (2002
51. De Paula VS, Perse AS, Amado LA et al. Kinetics of hepatitis A virus replication in vivo and in vitro using negative-strand quantitative PCR. Eur. J. Clin. Microbiol. Infect. Dis. 28(10), 1167.1176 (2009
52. De Paula VS, Diniz-Mendes L, Villar LM et al. Hepatitis A virus in environmental water samples from the Amazon Basin. Water Res. 41(6), 1169.1176 (2007
53. Donia D, Petrinca AR, Divizia M. A strategy to increase the specif.icity of Syber Green I qRT-PCR in hepatitis A detection. New Microbiol. 33(3), 215.222 (2010
54. Abd El Galil KH, El Sokkary MA, Kheira SM et al. Combined immunomagnetic separation-molecular beacon-reverse transcription-PCR assay for detection of hepatitis A virus from environmental samples. Appl. Environ. Microbiol. 70(7), 4371-4374 (2004).
55. Amado LA, Villar LM, de Paula VS, Gaspar AM. Comparison between serum and saliva for the detection of hepatitis A virus RNA. J. Virol. Methods 148(1-2), 74-80 (2008).
56. Villar LM, de Paula VS, Diniz-Mendes L et al. Molecular detection of hepatitis A virus in urban sewage in Rio de Janeiro, Brazil. Lett. Appl. Microbiol. 45(2), 168-173 (2007).
57. Tjon GM, Coutinho RA, van den Hoek A et al. High and persistent excretion of hepatitis A virus in immunocompetent patients. J. Med. Virol. 78(11), 1398-1405 (2006).
58. Gorchakova OV, Esaulenko EV, Mukomolov SL. [Duration of viral RNA circulation in blood of patients with hepatitis A]. Zh. Mikrobiol. Epidemiol. Immunobiol. 5, 20-23 (2007).
59. Costa-Mattioli M, Allavena C, Poirier AS, Billaudel S, Raffi F, Ferré V. Prolonged hepatitis A infection in an HIV-1 seropositive patient. J. Med. Virol. 68(1), 7-11 (2002).
60. Gallego M, Robles M, Palacios R et al. Impact of acute hepatitis A virus (HAV) infection on HIV viral load in HIV-infected patients and influence of HIV infection on acute HAV infection. J. Int .Assoc. Physicians AIDS Care (Chic.) 10(1), 40-42 (2011).
61. Fujiwara K, Yokosuka O, Imazeki F, Saisho H, Miki M, Omata M Do high levels of viral replication contribute to fulminant hepatitis .A Liver Int. 1 25 194-195 2005
62. Fujiwara K, Kojima H, Yasui S et al. Hepatitis A viral load in relation to severity of the infection. J. Med. Virol. 83(2), 201-207 (2011).
63. Hussain Z, Das BC, Husain SA et al. Virological course of hepatitis A virus as determined by real time RT-PCR: correlation with biochemical, immunological and genotypic profiles. World J. Gastroenterol. 12(29), 4683-4688 (2006).
64. Yalçin SS, Kondolot M, Göker H et al. Naturally acquired hepatitis A antibodies after haematopoetic stem cell transplantation. Epidemiol. Infect. 139(5), 683-687 (2011).
65. De Paula VS, Lu L, Niel C, Gaspar AM, Robertson BH. Genetic analysis of hepatitis A virus isolates from Brazil. J. Med. Virol. 73(3), 378-383 (2004).
66. Nainan OV, Xia G, Vaughan G, Margolis HS. Diagnosis of hepatitis a virus infection: a molecular approach. Clin. Microbiol. Rev. 19(1), 63-79 (2006).
67. Toyoda H, Kumada T, Kiriyama S et al. Clinical and molecular characteristics of hepatitis A virus infections during the years 1992-2003 in Ogaki, a centrally located city of Japan. J. Clin. Virol. 44(2), 145-148 (2009).
68. Yoon YK, Chun BC, Lee HK et al. Epidemiological and genetic analysis of a sustained community-wide outbreak of hepatitis A in the Republic of Korea, 2008: a hospital-based case-control study. J. Clin. Virol. 46(2), 184-188 (2009).
69. Sanger F, Nicklen S, Couldson AR. DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad. Sci. USA 74(12), 5463-5467 (1977).
70. Jansen RW, Siegl G, Lemon SM. Molecular epidemiology of human hepatitis A virus defined by an antigen-capture polymerase chain reaction method. Proc. Natl Acad. Sci. USA 87(8), 2867-2871 (1990).
71. Robertson BH, Khanna B, Nainan OV, Margolis HS. Epidemiologic patterns of wild-type hepatitis A virus determined by genetic variation. J. Infect. Dis. 163(2), 286-292 (1991).
72. Rico-Hesse R, Pallansch MA, Nottay BK, Kew OM. Geographic distribution of wild poliovirus type 1 genotypes. Virology 160(2), 311-322 (1987).
73. Hogle JM, Chow M, Filman DJ. Three-dimensional structure of poliovirus at 2.9 A resolution. Science 229(4720), 1358-1365 (1985).
74. Brown EA, Jansen RW, Lemon SM. Characterization of a simian hepatitis A virus (HAV): antigenic and genetic comparison with human HAV. J. Virol. 63(11), 4932-4937 (1989).
75. Nainan OV, Margolis HS, Robertson BH, Balayan M, Brinton MA. Sequence analysis of a new hepatitis A virus naturally infecting cynomolgus macaques (Macaca fascicularis). J. Gen. Virol. 72 (Pt 7), 1685-1689 (1991).
76. Costa-Mattioli M, Di Napoli A, Ferré V, Billaudel S, Perez-Bercoff R, Cristina J. Genetic variability of hepatitis A virus. J. Gen. Virol. 84(Pt 12), 3191-3201 (2003).
77. Lu L, Ching KZ, de Paula VS et al. Characterization of the complete genomic sequence of genotype II hepatitis A virus (CF53/Berne isolate). J. Gen. Virol. 85(Pt 10), 2943-2952 (2004).
78. Sánchez G, Bosch A, Ǵmez-Mariano G, Domingo E, Pint́ RM. Evidence for quasispecies distributions in the human hepatitis A virus genome. Virology 315(1), 34-42 (2003).
79. Costa-Mattioli M, Domingo E, Cristina J. Analysis of sequential hepatitis A virus strains reveals coexistence of distinct viral subpopulations. J. Gen. Virol. 87(Pt 1), 115-118 (2006).
80. Costa-Mattioli M, Ferre V, Monpoeho S et al. Genetic variability of hepatitis A virus in South America reveals heterogeneity and co-circulation during epidemic outbreaks. J. Gen. Virol. 82(Pt 11), 2647-2652 (2001).
81. Diaz BI, Sariol CA, Normann A, Rodríguez L, Flehmig B. Genetic relatedness of Cuban HAV wild-type isolates. J. Med. Virol. 64(2), 96-103 (2001).
82. De Paula VS, Saback FL, Gaspar AM, Niel C. Mixed infection of a child care provider with hepatitis A virus isolates from subgenotypes IA and IB revealed by heteroduplex mobility assay. J. Virol. Methods 107(2), 223-228 (2003).
83. Villar LM, Morais LM, Aloise R et al. Co-circulation of genotypes IA and IB of hepatitis A virus in Northeast Brazil. Braz. J. Med. Biol. Res. 39(7), 873-881 (2006).
84. Costa-Mattioli M, Monpoeho S, Schvoerer C et al. Genetic analysis of hepatitis A virus outbreak in France confirms the co-circulation of subgenotypes Ia, Ib and reveals a new genetic lineage. J. Med. Virol. 65(2), 233-240 (2001).
85. Heitmann A, Laue T, Schottstedt V, Dotzauer A, Pichl L. Occurrence of hepatitis A virus genotype III in Germany requires the adaptation of commercially available diagnostic test systems. Transfusion 45(7), 1097-1105 (2005).
86. Kulkarni MA, Walimbe AM, Cherian S, Arankalle VA. Full length genomes of genotype IIIA hepatitis A virus strains (1995-2008) from India and estimates of the evolutionary rates and ages. Infect. Genet. Evol. 9(6), 1287-1294 (2009).
87. Yun H, Lee HJ, Jang JH et al. Hepatitis A virus genotype and its correlation with the clinical outcome of acute hepatitis A in Korea: 2006-2008. J. Med. Virol. 83(12), 2073-2081 (2011).
88. Yoon YK, Yeon JE, Kim JH et al. Comparative analysis of disease severity between genotypes IA and IIIA of hepatitis A virus. J. Med. Virol. 83(8), 1308-1314 (2011).
89. Melgaço JG, Pinto MA, Rocha AM et al. The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccination. J. Med. Virol. 83(2), 208-217 (2011).
90. Wasley A, Fiore A, Bell BP. Hepatitis A in the era of vaccination. Epidemiol. Rev. 28, 101-111 (2006).
91. Lemon SM. Type A viral hepatitis: epidemiology, diagnosis, and prevention. Clin. Chem. 43(8 Pt 2), 1494-1499 (1997).
92. Desbois D, Roque-Afonso AM, Lebraud P, Dussaix E. Use of dried serum spots for serological and molecular detection of hepatitis a virus. J. Clin. Microbiol. 47(5), 1536-1542 (2009).
93. Judd A, Parry J, Hickman M et al. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J. Med. Virol. 71(1), 49-55 (2003).
94. Amado LA, Villar LM, de Paula VS, de Almeida AJ, Gaspar AM. Detection of hepatitis A, B, and C virus-specific antibodies using oral fluid for epidemiological studies. Mem. Inst. Oswaldo Cruz 101(2), 149-155 (2006).
95. Parry JV. Simple and reliable salivary tests for HIV and hepatitis A and B virus diagnosis and surveillance. Ann. NY Acad. Sci. 694, 216-233 (1993).
96. Ochnio JJ, Scheifele DW, Marion SA et al. Participant-collected, mail-delivered oral fluid specimens can replace traditional serosurveys: a demonstration-of-feasibility survey of hepatitis A virus-specific antibodies in adults. Can. J. Public Health 98(1), 37-40 (2007).
97. Tourinho RS, Amado LA, Villar LM et al. Importance of the cutoff ratio for detecting antibodies against hepatitis A virus in oral fluids by enzyme immunoassay. J. Virol. Methods 173(2), 169-174 (2011).
98. Ochnio JJ, Scheifele DW, Ho M, Mitchell LA. New, ultrasensitive enzyme immunoassay for detecting vaccine- and disease-induced hepatitis A virus-specific immunoglobulin G in saliva. J. Clin. Microbiol. 35(1), 98-101 (1997).
99. Challacombe SJ, Russell MW, Hawkes JE, Bergmeier LA, Lehner T. Passage of immunoglobulins from plasma to the oral cavity in rhesus monkeys. Immunology 35(6), 923-931 (1978).
100. Mackiewicz V, Dussaix E, Le Petitcorps MF, Roque-Afonso AM. Detection of hepatitis A virus RNA in saliva. J. Clin. Microbiol. 42(9), 4329-4331 (2004).
101. Rodríguez Lay Lde L, Larralde Díaz O, Martínez Casanueva R, Gutiérrez Moreno A. Anti-hepatitis A virus immunoglobulin M antibodies in urine samples for rapid diagnosis of outbreaks. Clin. Diagn. Lab. Immunol. 10(3), 492-494 (2003).
102. Joshi MS, Chitambar SD, Arankalle VA, Chadha MS. Evaluation of urine as a clinical specimen for diagnosis of hepatitis A. Clin. Diagn. Lab. Immunol. 9(4), 840-845 (2002).
103. Tencer J, Torffvit O, Thysell H, Rippe B, Grubb A. Proteinuria selectivity index based upon alpha 2-macroglobulin or IgM is superior to the IgG based index in differentiating glomerular diseases. Technical note. Kidney Int. 54(6), 2098-2105 (1998)